Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""dose–response"" wg kryterium: Temat


Tytuł:
The dose response of erythemal area and intensity on the unprotected skin fits well to a logistic 3P model in SPF tests of a Chinese population, which has the potential to improve the precision and consistency of minimal erythema dose determination.
Autorzy:
Qu D; Amway Innovation & Science, Ada, Michigan, USA.
Liao F; Amway (Shanghai) Innovation & Science Center, Shanghai, China.
Liu J; Amway (Shanghai) Innovation & Science Center, Shanghai, China.
Li X; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Ye C; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Zheng Y; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Xie X; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Yi J; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Lai W; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Pokaż więcej
Źródło:
Photodermatology, photoimmunology & photomedicine [Photodermatol Photoimmunol Photomed] 2023 Nov; Vol. 39 (6), pp. 633-641. Date of Electronic Publication: 2023 Sep 04.
Typ publikacji:
Journal Article
MeSH Terms:
Dose-Response Relationship, Radiation*
Erythema*/etiology
Ultraviolet Rays*/adverse effects
Humans ; East Asian People ; Logistic Models ; Skin/diagnostic imaging ; Skin/radiation effects
Czasopismo naukowe
Tytuł:
An interactive tool for designing efficient toxicology experiments.
Autorzy:
Gertsch W; Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA. .
Wong WK; Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.
Pokaż więcej
Źródło:
Archives of toxicology [Arch Toxicol] 2024 Mar; Vol. 98 (3), pp. 1015-1022. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article
MeSH Terms:
Research Design*
Algorithms*
Humans ; Dose-Response Relationship, Drug ; Benchmarking
Czasopismo naukowe
Tytuł:
Methylphenidate dose-response in children with ADHD: evidence from a double-blind, randomized placebo-controlled titration trial.
Autorzy:
Vertessen K; Clinical Neuropsychology Section, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. .; Department of Child and Adolescent Psychiatry, University Psychiatric Centre KU Leuven, Leuven, Belgium. .; Child Study Group, Clinical Neuropsychology Section, Vrije Universiteit Amsterdam, Van der Boechorststraat, 7-9, 1081 BT, Amsterdam, The Netherlands. .
Luman M; Clinical Neuropsychology Section, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Levvel Specialists in Youth and Family Care, Amsterdam, The Netherlands.
Swanson JM; Department of Pediatrics, University of California, Irvine, USA.
Bottelier M; Child Study Center Accare, UMC Groningen, Groningen, The Netherlands.
Stoffelsen R; Levvel Specialists in Youth and Family Care, Amsterdam, The Netherlands.
Bet P; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, VU Medical Center, Amsterdam, The Netherlands.
Wisse A; Youz, Center for Youth Menthal Healthcare, Velsen-Noord, The Netherlands.
Twisk JWR; Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, The Netherlands.
Oosterlaan J; Clinical Neuropsychology Section, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Emma Neuroscience Group, Department of Pediatrics, Amsterdam Reproduction and Development, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
European child & adolescent psychiatry [Eur Child Adolesc Psychiatry] 2024 Feb; Vol. 33 (2), pp. 495-504. Date of Electronic Publication: 2023 Mar 02.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Methylphenidate*/adverse effects
Attention Deficit Disorder with Hyperactivity*/drug therapy
Central Nervous System Stimulants*/adverse effects
Child ; Humans ; Child, Preschool ; Adolescent ; Dose-Response Relationship, Drug ; Double-Blind Method ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Generalized methods for predicting biological response to mixed radiation types and calculating equieffective doses (EQDX).
Autorzy:
Katugampola S; Department of Radiology and Center for Cell Signaling, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.
Hobbs RF; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Howell RW; Department of Radiology and Center for Cell Signaling, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.
Pokaż więcej
Źródło:
Medical physics [Med Phys] 2024 Jan; Vol. 51 (1), pp. 637-649. Date of Electronic Publication: 2023 Aug 21.
Typ publikacji:
Journal Article
MeSH Terms:
Radiation Exposure*
Dose-Response Relationship, Radiation ; Relative Biological Effectiveness
Czasopismo naukowe
Tytuł:
Drug combinations screening using a Bayesian ranking approach based on dose-response models.
Autorzy:
Boumendil L; Université Paris Cité, INSERM U1153, Team ECSTRRA, Paris, France.
Fontaine M; Université Paris Cité, Génomes, biologie cellulaire et thérapeutique U944, INSERM, CNRS, Paris, France.
Lévy V; Université Paris Cité, INSERM U1153, Team ECSTRRA, Paris, France.; Sorbonne Paris Nord, Unité de Recherche Clinique, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, France.
Pacchiardi K; Université Paris Cité, Génomes, biologie cellulaire et thérapeutique U944, INSERM, CNRS, Paris, France.; Laboratoire d'Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
Itzykson R; Université Paris Cité, Génomes, biologie cellulaire et thérapeutique U944, INSERM, CNRS, Paris, France.; Service Hématologie Adultes, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
Biard L; Université Paris Cité, INSERM U1153, Team ECSTRRA, Paris, France.; Service de Biostatistique et Information Médicale, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
Pokaż więcej
Źródło:
Biometrical journal. Biometrische Zeitschrift [Biom J] 2024 Jan; Vol. 66 (1), pp. e2200332. Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols*
Neoplasms*/drug therapy
Humans ; Bayes Theorem ; Drug Combinations ; Research Design ; Sample Size ; Dose-Response Relationship, Drug
Czasopismo naukowe
Tytuł:
Ionizing radiation responses appear incidental to desiccation responses in the bdelloid rotifer Adineta vaga.
Autorzy:
Moris, Victoria C. (AUTHOR)
Bruneau, Lucie (AUTHOR)
Berthe, Jérémy (AUTHOR)
Heuskin, Anne-Catherine (AUTHOR)
Penninckx, Sébastien (AUTHOR)
Ritter, Sylvia (AUTHOR)
Weber, Uli (AUTHOR)
Durante, Marco (AUTHOR)
Danchin, Etienne G. J. (AUTHOR)
Hespeels, Boris (AUTHOR)
Doninck, Karine Van (AUTHOR)
Pokaż więcej
Źródło:
BMC Biology. 1/25/2024, Vol. 22 Issue 1, p1-27. 27p.
Czasopismo naukowe
Tytuł:
Assembling Au8 clusters on surfaces of bifunctional nanoimmunomodulators for synergistically enhanced low dose radiotherapy of metastatic tumor.
Autorzy:
Zhang, Rui (AUTHOR)
Jia, Mengchao (AUTHOR)
Lv, Hongying (AUTHOR)
Li, Mengxuan (AUTHOR)
Ding, Guanwen (AUTHOR)
Cheng, Ge (AUTHOR)
Li, Juan (AUTHOR)
Pokaż więcej
Źródło:
Journal of Nanobiotechnology. 1/5/2024, Vol. 22 Issue 1, p1-16. 16p.
Czasopismo naukowe
Tytuł:
Role of the mechanical microenvironment on CD-44 expression of breast adenocarcinoma in response to radiotherapy.
Autorzy:
Frascogna, Crescenzo (AUTHOR)
Mottareale, Rocco (AUTHOR)
La Verde, Giuseppe (AUTHOR)
Arrichiello, Cecilia (AUTHOR)
Muto, Paolo (AUTHOR)
Netti, Paolo A. (AUTHOR)
Pugliese, Mariagabriella (AUTHOR)
Panzetta, Valeria (AUTHOR)
Pokaż więcej
Źródło:
Scientific Reports. 1/3/2024, Vol. 13 Issue 1, p1-12. 12p.
Czasopismo naukowe
Tytuł:
Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers: A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study.
Autorzy:
Yuan G; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Chen Y; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Li L; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Wang X; Global R&D Center, Shanghai Fosun Pharmaceutical Development, Co., Ltd, Shanghai, China.
Wei G; Global R&D Center, Shanghai Fosun Pharmaceutical Development, Co., Ltd, Shanghai, China.
Zeng J; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Hui AM; Global R&D Center, Shanghai Fosun Pharmaceutical Development, Co., Ltd, Shanghai, China.
Jiang Y; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Zhao H; Global R&D Center, Shanghai Fosun Pharmaceutical Development, Co., Ltd, Shanghai, China.
Diao L; Global R&D Center, Shanghai Fosun Pharmaceutical Development, Co., Ltd, Shanghai, China.
Zhou Y; Wanbang Biopharmaceuticals, Xuzhou, Jiangsu, China.
Xiao Y; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Chen M; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
International journal of clinical practice [Int J Clin Pract] 2024 Mar 06; Vol. 2024, pp. 1386980. Date of Electronic Publication: 2024 Mar 06 (Print Publication: 2024).
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article
MeSH Terms:
Sulfonamides*
Irritable Bowel Syndrome*
Humans ; Isoquinolines/adverse effects ; Isoquinolines/pharmacokinetics ; Area Under Curve ; Double-Blind Method ; Healthy Volunteers ; China ; Dose-Response Relationship, Drug
Czasopismo naukowe
Tytuł:
Exploring various measures of the area under the curve for the assessment of dose-proportionality and estimation of bioavailability.
Autorzy:
Brocks DR; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
Minthorn EA; Glaxo SmithKline Pharmaceuticals, Collegeville, PA 19426, United States.
Davies BE; Retired, Doylestown, PA 18901, United States.; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
Pokaż więcej
Źródło:
The Journal of pharmacy and pharmacology [J Pharm Pharmacol] 2024 Mar 04; Vol. 76 (3), pp. 245-256.
Typ publikacji:
Journal Article
MeSH Terms:
Biological Availability*
Area Under Curve ; Dose-Response Relationship, Drug ; Cross-Over Studies
Czasopismo naukowe
Tytuł:
Pharmacokinetics, Safety Profile, and Tolerability of Tetramethylpyrazine Nitrone Tablets After Single and Multiple Ascending Doses in Healthy Chinese Volunteers.
Autorzy:
Zhu G; Haikou People's Hospital and Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, Hainan, China.
Wang L; Haikou People's Hospital and Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, Hainan, China.
Zhong S; Haikou People's Hospital and Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, Hainan, China.
Han S; Haikou People's Hospital and Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, Hainan, China.
Peng H; Haikou People's Hospital and Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, Hainan, China.
Tong M; Haikou People's Hospital and Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, Hainan, China.
He X; Haikou People's Hospital and Affiliated Haikou Hospital of Xiangya Medical School, Central South University, Haikou, Hainan, China. .
Pokaż więcej
Źródło:
European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 Mar; Vol. 49 (2), pp. 207-217. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Healthy Volunteers*
Pyrazines*
Humans ; Male ; Female ; Area Under Curve ; Administration, Oral ; Tablets ; China ; Double-Blind Method ; Dose-Response Relationship, Drug
Czasopismo naukowe
Tytuł:
Safety, pharmacokinetics and pharmacodynamics of HRS-7535, a novel oral small molecule glucagon-like peptide-1 receptor agonist, in healthy participants: A phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose, and food effect trial.
Autorzy:
Wu J; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhou R; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhang Q; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Zhang Q; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Qin H; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Ye Z; Clinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Xu Y; Clinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Feng S; Clinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Shu C; Clinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Shen Y; Clinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Fan Y; Clinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Wang Q; Clinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai, China.
Du Y; The Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Hu W; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
Pokaż więcej
Źródło:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Mar; Vol. 26 (3), pp. 901-910. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/drug therapy
Humans ; Glucagon-Like Peptide-1 Receptor Agonists ; Healthy Volunteers ; Body Weight ; Area Under Curve ; Double-Blind Method ; Dose-Response Relationship, Drug
Czasopismo naukowe
Tytuł:
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Anti-IFNAR1 Monoclonal Antibody QX006N: A First-in-Human Single Ascending Dose Study in Healthy Chinese Volunteers.
Autorzy:
Li X; Phase I Clinical Trial Center, First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, 130021, China.
Li B; Phase I Clinical Trial Center, First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, 130021, China.
Wang M; Phase I Clinical Trial Center, First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, 130021, China.
Fang M; Qyuns Therapeutics Co., Ltd., Jiangsu, China.
Lou J; Phase I Clinical Trial Center, First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, 130021, China.
Liu J; Phase I Clinical Trial Center, First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, 130021, China.
Chen H; Phase I Clinical Trial Center, First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, 130021, China.
Ding Y; Phase I Clinical Trial Center, First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, 130021, China. .
Pokaż więcej
Źródło:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2024 Mar; Vol. 38 (2), pp. 313-321. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article
MeSH Terms:
Antibodies, Monoclonal*/adverse effects
Antibodies, Monoclonal*/pharmacokinetics
Receptor, Interferon alpha-beta*
Humans ; Healthy Volunteers ; Infusions, Intravenous ; Area Under Curve ; Double-Blind Method ; China ; Dose-Response Relationship, Drug
Czasopismo naukowe
Tytuł:
The imidazoline I 2 receptor agonist 2-BFI reduces abuse-related effects of morphine: self-administration and drug discrimination.
Autorzy:
Siemian JN; Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
Woodhouse K; Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
Liu DH; Episcopal High School, Alexandria, VA, USA.
Zhang Y; Research Triangle Institute, Research Triangle Park, NC, USA.
Li JX; Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA. .
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2024 Mar; Vol. 241 (3), pp. 479-487. Date of Electronic Publication: 2023 Dec 30.
Typ publikacji:
Journal Article
MeSH Terms:
Morphine*/pharmacology
Morphine*/therapeutic use
Imidazolines*
Benzofurans*
Imidazoles*
Rats ; Animals ; Analgesics, Opioid/pharmacology ; Analgesics, Opioid/therapeutic use ; Rats, Sprague-Dawley ; Pain/drug therapy ; Dose-Response Relationship, Drug ; Imidazoline Receptors/agonists
Czasopismo naukowe
Tytuł:
Radiation exposure lymphocyte damage assessed by γ-H2AX level using flow cytometry.
Autorzy:
Chen Z; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Wakabayashi H; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan. .
Kuroda R; Department of Pediatrics, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Mori H; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Hiromasa T; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Kayano D; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Kinuya S; Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 22; Vol. 14 (1), pp. 4339. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Histones*/genetics
Radiation Exposure*
Mice ; Animals ; Iodine Radioisotopes ; Dose-Response Relationship, Radiation ; Flow Cytometry/methods ; Lymphocytes/radiation effects ; DNA Damage
Czasopismo naukowe
Tytuł:
An extended Bayesian semi-mechanistic dose-finding design for phase I oncology trials using pharmacokinetic and pharmacodynamic information.
Autorzy:
Yang C; Department of Biostatistics, Division of VP, Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Li Y; Department of Biostatistics, Division of VP, Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Statistics in medicine [Stat Med] 2024 Feb 20; Vol. 43 (4), pp. 689-705. Date of Electronic Publication: 2023 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*/drug therapy
Humans ; Bayes Theorem ; Computer Simulation ; Biomarkers ; Maximum Tolerated Dose ; Dose-Response Relationship, Drug ; Research Design
Czasopismo naukowe
Tytuł:
Synthesis and Antitumor Activity Evaluation of Novel Echinatin Derivatives with a 1,3,4-Oxadiazole Moiety.
Autorzy:
Tian X; Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Sun Z; Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Zhong Y; Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yang H; Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Cheng M; Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Liu Y; Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 13; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/chemistry
Neoplasms*
Oxadiazoles*
Chalcones*
Humans ; Structure-Activity Relationship ; Drug Screening Assays, Antitumor ; Molecular Docking Simulation ; Cell Proliferation ; Molecular Structure ; Cell Line, Tumor ; Dose-Response Relationship, Drug
Czasopismo naukowe
Tytuł:
A new function for drug combination dose finding trials.
Autorzy:
Xiao J; Department of Financial and Actuarial Mathematics, Xi'an Jiaotong-Liverpool University, Suzhou, 215123, Jiangsu, China.
Zhang W; Department of Financial and Actuarial Mathematics, Xi'an Jiaotong-Liverpool University, Suzhou, 215123, Jiangsu, China. vivian_.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 12; Vol. 14 (1), pp. 3483. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Research Design*
Reproducibility of Results ; Maximum Tolerated Dose ; Dose-Response Relationship, Drug ; Computer Simulation ; Bayes Theorem
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies